Farmacie pro praxi. 2023;19(4):226-231 [Med. praxi. 2023;20(3):171-178]

Treatment of chronic pain-up to date

MUDr. Pavlína Nosková, Ph.D.
KARIM VFN a 1. LF UK Praha

Chronic pain is a serious health problem that puts a strain on the entire health system. Her treatment should be conducted rationally and on the basis of current scientific knowledge. The article summarizes the current view of this issue and points to new painkillers and recommendations.

Keywords: new pain definition, nociplastic pain, nonsteroid antiinflamatory drugs, combine analgesics, opioids, opioid induced obstipation.

Published: December 23, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P. Treatment of chronic pain-up to date. Pharmacy for Practice. 2023;19(4):226-231.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976-1982. Go to original source... Go to PubMed...
    2. Skála B, Kozák J. Doporučené diagnostické a terapeutické postupy pro všeobecné lékaře: Léčba bolesti 2021. [cited 7. 4. 2023]. Available from: https://www.svl.cz/files/files/Doporucene­‑postupy/2020/DP­‑Bolest.pdf.
    3. Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157: 1382-1386. Go to original source... Go to PubMed...
    4. Pergolizzi J, Raffa R. The WHO Pain Ladder: Do We Need Another Step? Pract Pain Manag. 2014;14(1).
    5. Prokeš M, Suchopár J. Kombinovaná analgetika­‑antipyretika a jejich rizika. Med praxi. 2015;12(5):247-251.
    6. Kršiak M. Jak zvýšit analgetickou potenci paracetamolu? Prakt lékáren. 2012;8(5):214-216.
    7. Rozsívalová P, Štichhauer R, Holická L, et al. Metamizol v léčbě bolesti u dětské populace. Pediatr praxi. 2020;21(5): 323-329. Go to original source...
    8. Miljković MN, Rančič NK, Simić RM, et al. Metamizole: Current Status of the Safety and Efficacy. Hospital Pharmacology. 2018;5(3):694-704. Go to original source...
    9. Kršiak M, Doležal T, Lejčko J. Neopioidní analgetika in: Bolest. 2. vydání Praha: Tigis; 2012.
    10. Informační dopis - Metamizol: Riziko léky indukovaného poškození jater. SÚKL 2020. [cited 7. 4. 2023], Available from: https://www.sukl.cz/leciva/informacni­‑dopis­‑metamizol­‑riziko­‑leky­‑indukovaneho poškození jater.
    11. Lejčko J, Kozák J, Fricová J, et al. Metodické pokyny pro farmakoterapii bolesti. Bolest. 2016;19(suppl 1). www.tigis.cz.
    12. Gabrhelík T. Chyby v léčbě bolesti. Bolest. 2023;26(1):17-23.
    13. Salmonson H, Sjoberg G, Brogren J. The standard treatment protocol for paracetamol poisoning may be inadequate following overdose with modified release formulation: a pharmacokinetic and clinical analysis of 53 cases. Clin Toxicol(Phila). 2017;6(23):1-6. Go to original source... Go to PubMed...
    14. Cetalgen, SPC [cited 7. 4. 2023], Available from: www.sukl.cz.
    15. Skudexa, SPC [cited 7. 4. 2023], Available from: www.sukl.cz.
    16. Dowell D, Ragan KR, Jones CM, et al. CDC Clinical practice guideline for prescribing opioids for pain­‑United States. 2022. MMWR Recomm Rep. 2022;71(3):1-95. Go to original source... Go to PubMed...
    17. Channell JS, Schug S. Toxicity of tapentadol:a systematic review. Pain manag. 2018;8(5):327-339. Go to original source... Go to PubMed...
    18. Fricová J, Hakl M. Farmakoterapie nenádorové průlomové bolesti. Metodické pokyny pro farmakoterapii bolesti - speciální část. Bolest. 2017;20 (suppl1):7.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.